Picture of Algorae Pharmaceuticals logo

1AI Algorae Pharmaceuticals Balance Sheet

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments4.912.961.614.244.11
Net Total Accounts Receivable
Net Total Receivables0.4660.0980.0140.030.096
Total Inventory
Prepaid Expenses
Total Current Assets5.43.071.634.274.21
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.2780.2760.0160.0050.005
Long Term Investments
Total Assets5.763.391.644.274.21
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.620.3110.2650.2390.45
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1.620.5130.2650.2390.45
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity4.142.881.384.033.76
Total Liabilities & Shareholders' Equity5.763.391.644.274.21
Total Common Shares Outstanding